18.92

1.34% 0.25

After Hours: 19.14 0.22 +1.16%

Pulse Biosciences Inc (PLSE)

Overview News Price History Option Chain Financials Discussions Forecast

Pulse Biosciences Inc stock is traded at $18.92, with a volume of 194.09K. It is up +1.34% in the last 24 hours and down -12.29% over the past month. Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

Previous Close:

$18.67

Open:

$18.7

24h Volume:

194.09K

Relative Volume:

0.59

Market Cap:

$1.29B

Revenue:

$350.00K

Net Income/Loss:

$-72.78M

P/E Ratio:

-17.52

EPS:

-1.08

Net Cash Flow:

$-54.46M

1W Performance:

-17.52%

1M Performance:

-12.29%

6M Performance:

+9.17%

1Y Performance:

+17.96%

1-Day Range:

$18.22

$19.19

1-Week Range:

$17.75

$22.55

52-Week Range:

$12.56

$26.30

Pulse Biosciences Inc Stock (PLSE) Company Profile

Name

Pulse Biosciences Inc

Sector

Healthcare (1108)

Industry

Medical Instruments & Supplies (57)

Phone

510-906-4600

Address

3957 POINT EDEN WAY, HAYWARD, CA

Employee

116

Twitter

@PulseBioNPS

Next Earnings Date

2024-10-30

Latest SEC Filings

PLSE's Discussions on Twitter

Compare PLSE vs ISRG, BDX, ALC, MDLN, RMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PLSE Pulse Biosciences Inc	18.92	1.27B	350.00K	-72.78M	-54.46M	-1.08
ISRG Intuitive Surgical Inc	458.96	160.05B	10.06B	2.88B	2.49B	7.876
BDX Becton Dickinson Co	155.43	43.87B	21.92B	1.76B	2.63B	6.1223
ALC Alcon Inc	79.74	38.02B	10.40B	980.00M	1.61B	1.9749
MDLN Medline Inc	47.22	37.01B	28.43B	1.16B	1.26B	1.4457
RMD Resmed Inc	230.26	33.34B	5.40B	1.49B	1.78B	10.12

Pulse Biosciences Inc Stock (PLSE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-30-26	Initiated	Mizuho	Outperform
Jul-07-25	Initiated	Oppenheimer	Outperform
Jul-27-21	Initiated	Stephens	Overweight
Mar-11-21	Initiated	Maxim Group	Buy
Jan-26-21	Reiterated	H.C. Wainwright	Buy
May-12-20	Upgrade	H.C. Wainwright	Neutral → Buy
Feb-14-20	Downgrade	H.C. Wainwright	Buy → Neutral
Feb-25-19	Initiated	H.C. Wainwright	Buy

View All

Pulse Biosciences Inc Stock (PLSE) Latest News

11:24 AM

Income Plays: Does Pulse Biosciences Inc have strong fundamentalsPortfolio Update Summary & Reliable Price Breakout Signals - baoquankhu1.vn

11:24 AM

09:50 AM

Pulse Biosciences Initiates Patient Enrollment in NANOPULSE-AF Study - TradingView — Track All Markets

09:50 AM

Apr 12, 2026

Pulse Biosciences Inc at TD Cowen Healthcare Conference Transcript - GuruFocus

Apr 12, 2026

Can Pulse Biosciences’ (PLSE) New AF Study and C-Suite Hires Reframe Its PFA Strategy? - Yahoo Finance

Apr 12, 2026

Apr 11, 2026

Q4 2025 Pulse Biosciences Inc Earnings Call Transcript - GuruFocus

Apr 11, 2026

Apr 10, 2026

Pulse Biosciences hires Liane Teplitsky as COO - MedTech Dive

Apr 10, 2026

PLSE Stock Price, Quote & Chart | PULSE BIOSCIENCES INC (NASDAQ:PLSE) - ChartMill

Apr 10, 2026

Apr 09, 2026